
Collegium Pharmaceutical Inc
NASDAQ:COLL

Collegium Pharmaceutical Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
24.67
41.86
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Collegium Pharmaceutical Inc hold over its rivals?
What risks and challenges
does Collegium Pharmaceutical Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Collegium Pharmaceutical Inc.
Provide an overview of the primary business activities
of Collegium Pharmaceutical Inc.
What unique competitive advantages
does Collegium Pharmaceutical Inc hold over its rivals?
What risks and challenges
does Collegium Pharmaceutical Inc face in the near future?
Has there been any significant insider trading activity
in Collegium Pharmaceutical Inc recently?
Summarize the latest earnings call
of Collegium Pharmaceutical Inc.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Collegium Pharmaceutical Inc.
Provide P/S
for Collegium Pharmaceutical Inc.
Provide P/E
for Collegium Pharmaceutical Inc.
Provide P/OCF
for Collegium Pharmaceutical Inc.
Provide P/FCFE
for Collegium Pharmaceutical Inc.
Provide P/B
for Collegium Pharmaceutical Inc.
Provide EV/S
for Collegium Pharmaceutical Inc.
Provide EV/GP
for Collegium Pharmaceutical Inc.
Provide EV/EBITDA
for Collegium Pharmaceutical Inc.
Provide EV/EBIT
for Collegium Pharmaceutical Inc.
Provide EV/OCF
for Collegium Pharmaceutical Inc.
Provide EV/FCFF
for Collegium Pharmaceutical Inc.
Provide EV/IC
for Collegium Pharmaceutical Inc.
Show me price targets
for Collegium Pharmaceutical Inc made by professional analysts.
What are the Revenue projections
for Collegium Pharmaceutical Inc?
How accurate were the past Revenue estimates
for Collegium Pharmaceutical Inc?
What are the Net Income projections
for Collegium Pharmaceutical Inc?
How accurate were the past Net Income estimates
for Collegium Pharmaceutical Inc?
What are the EPS projections
for Collegium Pharmaceutical Inc?
How accurate were the past EPS estimates
for Collegium Pharmaceutical Inc?
What are the EBIT projections
for Collegium Pharmaceutical Inc?
How accurate were the past EBIT estimates
for Collegium Pharmaceutical Inc?
Compare the revenue forecasts
for Collegium Pharmaceutical Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Collegium Pharmaceutical Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Collegium Pharmaceutical Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Collegium Pharmaceutical Inc compared to its peers.
Compare the P/E ratios
of Collegium Pharmaceutical Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Collegium Pharmaceutical Inc with its peers.
Analyze the financial leverage
of Collegium Pharmaceutical Inc compared to its main competitors.
Show all profitability ratios
for Collegium Pharmaceutical Inc.
Provide ROE
for Collegium Pharmaceutical Inc.
Provide ROA
for Collegium Pharmaceutical Inc.
Provide ROIC
for Collegium Pharmaceutical Inc.
Provide ROCE
for Collegium Pharmaceutical Inc.
Provide Gross Margin
for Collegium Pharmaceutical Inc.
Provide Operating Margin
for Collegium Pharmaceutical Inc.
Provide Net Margin
for Collegium Pharmaceutical Inc.
Provide FCF Margin
for Collegium Pharmaceutical Inc.
Show all solvency ratios
for Collegium Pharmaceutical Inc.
Provide D/E Ratio
for Collegium Pharmaceutical Inc.
Provide D/A Ratio
for Collegium Pharmaceutical Inc.
Provide Interest Coverage Ratio
for Collegium Pharmaceutical Inc.
Provide Altman Z-Score Ratio
for Collegium Pharmaceutical Inc.
Provide Quick Ratio
for Collegium Pharmaceutical Inc.
Provide Current Ratio
for Collegium Pharmaceutical Inc.
Provide Cash Ratio
for Collegium Pharmaceutical Inc.
What is the historical Revenue growth
over the last 5 years for Collegium Pharmaceutical Inc?
What is the historical Net Income growth
over the last 5 years for Collegium Pharmaceutical Inc?
What is the current Free Cash Flow
of Collegium Pharmaceutical Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Collegium Pharmaceutical Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
US |
![]() |
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
1B USD | 5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
770.2B USD | 37.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
404.9B USD | 13.6 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.2B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.7B CHF | 10 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.5B GBP | 131.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
213.1B USD | 9 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
140.9B USD | 7.6 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
US |
![]() |
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
Average EV/EBITDA:
397.7
5
|
4%
|
1.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
37.2
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.6
|
7%
|
1.9 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.3
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10
|
5%
|
2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131.1
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
9
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.6
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.